Abstract
Three-dimensional (3D) printing enables patient-specific anatomical level productions with high adjustability and resolution in microstructures. With cost-effective manufacturing for high productivity, 3D printing has become a leading healthcare and pharmaceutical manufacturing technology, which is suitable for variety of applications including tissue engineering models, anatomical models, pharmacological design and validation model, medical apparatus and instruments. Today, 3D printing is offering clinical available medical products and platforms suitable for emerging research fields, including tissue and organ printing. In this review, our goal is to discuss progressive 3D printing technology and its application in medical materials. The additive overview also provides manufacturing techniques and printable materials.
Introduction
As an additive manufacturing (AM) technique, three-dimensional (3D) printing enables customized fabrication of 3D constructs based on computer aided design (CAD) software or images obtained from computed tomography (CT) and magnetic resonance imaging (MRI). Firstly developed in the 1980s, 3D printing technology was called rapid prototype technology and has been well applied in a variety of industries with different printing techniques and materials (). With the rapid development of 3D printer, the overall 3D printing market grew to $9.9 billion in 2018 and is expected to reach $34.8 billion in 2024 (). The medical 3D printing market is expected to maintain significant growth due to the huge potential demand for costumed medical products. Currently, with the expiry of many 3D printing patents (including stereolithography and selective laser sintering), 3D printers and products are becoming cheaper and easy to access ().
3D printing technology has been widely applied in a variety of industries including aviation (), geoscience (), education (), clothing (), medical (; ), and pharmaceuticals (; ; ). Among these medical and pharmaceutical industries, orthopedic and dental applications are favorable to embrace the 3D printing technology (). It is related to the demand for the patient-specific design and fabrication of the final devices (such as joint prosthesis, surgical guides, and dental restorations) (; ). Personalized devices manufactured preoperationally are benefited for the efficiency and accuracy (). For medical education and surgical planning, 3D anatomical models are printed subtly with microscopic anatomy structures (; ). Tissue and organ printing is an emerging field that mainly focused on regenerative medicine and tissue engineering by both academy and industry (). Based on it, preclinical patient-specific disease models are used for drug testings and screenings. 3D printing technology is merging with traditional pharmaceuticals for the development of dose-customized drugs ().
In this review, recent techniques and applications of 3D printing in medical materials are well summarized. Common AM techniques and printable materials are presented for better understanding of their potential, limitations, and applications. Medical applications including tissue engineering, anatomical models, apparatus, and instruments with 3D printing technology are also provided and summarized. We finally demonstrate our concluding remarks and future outlook on 3D printing in medical materials (Figure 1).
Figure 1
Current am Technologies and Printable Materials
There are about two dozen AM techniques, among which only some techniques are widely applied in medical industry. The main reason is the specific fabrication process and raw material to meet the high-quality requirements for medical devices. Four common AM techniques are powder-based printing (), vat polymerization-based printing (), droplet-based printing (), and extrusion-based printing ().
Powder-Based Printing
Powder-based 3D printing is a promising technique with excellent ability for customized fabrication with a variety of external shapes, internal structures, and porosities. There are four common powder-based printing techniques: selective laser sintering (SLS), selective laser melting (SLM), direct metal laser sintering (DMLS), and electron beam melting (EBM) (Figure 2) (). Every technique is based on localized heating to generate melted metallic powder, which would be used to fabricate the customized products. There are obvious differences in both printing process and product characters among these four powder-based printing techniques. For SLS and DMLS, powder particles are bounded with laser instead of spray solution. In the printing process, the laser draws specific patterns on one layer of the powder bed (). The roller in the printer distributes a new layer of powder onto the surface once the printing of the previous layer is completed. After being built layer-by-layer, printed objects are collected underneath the powder bed. As a specific kind of SLS, DMLS utilizes metal exclusively. Different from sintering techniques, SLM and EBM fully melt powder with laser and electron beam respectively (). For the work of electron beam, the powder bed in the EBM printer maintains high working temperature (> 870 K). It directly affects the quality of the fabrication especially in the details of microstructure. Comparatively, products printed with SLM maintain higher tribological, mechanical, and corrosion properties. With the differences between sintering and melting, the surfaces of products printed with sintering techniques (SLS and DMLS) are rough as powders are not completely melted.
Figure 2
Although the sintering techniques produce products with rough surfaces, they can process with a large variety of materials including plastic powder, ceramic powder, and metal alloys. As the high working temperature, material with volatile constituents (Mg, Zn, Bi, etc.) are not feasible for EBM, while SLM can treat a much wider spectrum of metallic alloys including Ti-based, Al-based, Fe-based, Ni-based, Cu-based, Co-based, and their composites. However, the melting process brings a big advantage that it can produce fully dense parts without post-treatment steps such as infiltration or thermal process.
Vat Polymerization-Based Printing
Vat-polymerization based printing technique is based on light curing resin material and light selective hardening polymerization molding. It is widely used for fabricating complex devices with functional parts such as valves, lenses and fluidic interconnects (). In the process, a vat of photosensitive polymer resin is selectively exposed to a specifically controlled beam of leaser or light (; ). The polymer is polymerized after spatially localized irradiation to fabricate the specific constructions (; ). Common process includes digital light processing (DLP), stereolithography (SLA), and multiphoton polymerization (MPP) (Figure 3) (). SLA was the first AM technology applied in medicine in 1994 (). A spot laser irradiates the resin localized in a single x-y direction in SLA (), whereas a digital illuminant irradiates the whole x-y plan in DLP (). For both SLA and DLP, the print platform moves parallelly to the z-axis while the final product is fabricated layer-by-layer (; ). Differently in MPP, the photosensitive polymer resin is irradiated by a femtosecond laser beam thoroughly in multi directions, resulting that it is not a layer-by-layer technology (). Products printed with vat polymerization technology need to be exposed to light after printing to enhance stability (; ).
Figure 3
Droplet-Based Printing
Material jetting technology is a process where droplets of liquid materials are ejected and polymerized throughout hundreds of jets. The polymerization only occurs selectively by directed UV for designed structures (). Material jetting technology includes aerosol jet printing (AJP), binder jet printing (BJP), and poly jet printing (PJP) (Figure 4). During AJP, composite in aerosol suspension droplets is carried via N2 gas and ejected onto the substrate layer by layer (). Multi materials including metals, polymers, and ceramics can be used in AJP with a low printing temperature, which is benefit for biomanufacturing (). Binder jet printing (BJP) is similar with SLS except that BJP do not need thermoplastic excipient (). The binder in BJP should meet specific ranges of surface tension (35–40 mJ/N) and viscosity (5–20 Pa·s) (). In PJP, polymer resin drops are cured by UV light immediately without time consuming postprocessing (). With high resolution, PJP is capable of printing refined structures ().
Figure 4
Extrusion-Based Printing
Extrusion-based printing was firstly developed by S. Scott Crump in 1988, commonly referred as fused deposition modeling (FDM) or fused filament fabrication (FFF) (). FDM is a mature technology based on the extrusion of thermoplastic or composite materials drawn through the hot extrusion head (with one/multiple extrusion nozzles) (). Fused materials were deposited layer by layer with the horizontal and vertical movement of nozzles controlled by numerically-controlled machine tool (). Extrusion-based printing widely applied in metal printing, polymer printing, and bioprinting (Figure 5) (). The printing techniques have been recently developed to precision extrusion deposition (PED) (), precise extrusion manufacturing (PEM) (), and multiple heads deposition extrusion (MHDS) (). Multiple bioprinting applications in vascular models, soft-tissue models, and bone models manufactured with extrusion-based printing technology have been well-developed in recent years (; ; ). One major advantage of its bioprinting application is that the hydrogels of extrusion-based printing is capable to fabricate products with high cell density (> 1 × 106 cells ml−1) (; ; ).
Figure 5
Applications in Medical Materials
AM technologies have been widely applied in medical materials, especially in tissue engineering, medical models, medical instruments, and drug formulations. A variety of printing technologies and products have lightened the broad market of medical and chemical applications of 3D printing.
Functional Biomaterials for Tissue Engineering
Tissue engineering with 3D printing has been focused on two parts, functional biomaterials for tissue implantation and tissue models for disease studies. In this section, functional biomaterials manufactured with AM technologies would be the focus. Tissue scaffolds are important component of 3D printing tissue engineering as they can provide structural supports for cell attachment, proliferation and migration (Figure 6). Tissue engineering scaffolds and basic medical scaffolds are considered different especially in biological activity and application purposes (). Good bioactivity, excellent biocompatibility, and appropriate mechanical property are three basic requirements for an ideal tissue engineering scaffold. While basic medical scaffolds are usually applied for filling tissue coloboma or fixation without requirement for bioactivity. Implantable tissue engineering scaffolds are required to be degradable where scaffolds would be replaced by palingenetic tissues (). To induce tissue or bone growth inside the scaffolds, traditional procedures including molding, freeze drying, and electrospinning have been applied in the manufacture. However, none of the traditional procedures can fabricate scaffolds with customized mechanics, architecture and porosity. With the development of AM, scaffolds with high resolution, customized design, and high porosity have been successful in medical applications.
Figure 6
Tissue engineering scaffolds are fabricated in two major methods, printing with cells mixed in ink or gel and seeding cells onto scaffolds post printing. The most common methods applied in scaffolds fabrication are vat polymerization, SLS, BJ, and FDM. Inkjet printing and extrusion-based printing are the two popular bioprinting technologies, while bio-scaffolds are fabricated based on or without scaffolds. For bioprinting techniques based on scaffolds, hydrogels or polymers laden with cells are cured with AJP, BJP, PJP, and vat polymerization. For bioprinting techniques without scaffolds, hydrogels filled with high cell density (> 1 × 106 cells ml−1) are applied directly relying on cell-cell interactions. Cells in such density need to fuse and mature in the bioreactor for a period of time.
Only a few companies have launched commercial tissue engineering scaffolds. Organogenesis Inc, one of the world's most famous FDA-approved 3D printed medical device supplier, introduced their GINTUIT™, a tissue engineering product approved in 2012 for oral soft tissue repair and regeneration. It is a commercialized cell and gene therapy product combined fibroblasts and keratinocytes in bovine collagen. In 2016, another famous supplier, Stryker released the product Tritanium® LP, a titanium lumber posterior cage. The lumber cage is fabricated with abundant porous by DMLS technology with titanium alloy. The inner porous are helpful for blood vessel and bone growth inside the lumber cage.
With widespread concerns from various industries, bioprinting and tissue engineering have made significant progress and wide applications. Applications covered profuse tissues including tooth, bone, cartilage, ear, blood vessel, liver, kidney, and myocardium (). In 2017, Monica M. Laronda et al. from Northwestern university claimed successful fabrication of a bioprosthetic ovary created using 3D printed microporous scaffolds restoring ovarian function in sterilized mice (). Recently, Byoung Soo Kim and his colleges developed human skin with PJP 3D printing system (). This printed skin showed favorable biological characteristics, including stable dermis and epidermal layers. Manufactured skin substitutes can significantly improve skin healing of the wound area.
Anatomical and Pharmacological Models
To date, 3D printed tissue models play a significant role in the studies of mechanism of disease, pharmacological testing for new drugs, effectiveness of preclinical therapy, and anatomical structures of complicated organs (Figures 7 and 8). For these studies, conventional methods take plenty of mice and other experiment animals for building animal models. Typically, patient derived xenograft (PDX) models for medical studies always cost a large amount of immunodeficient mice to engraft disease cells. This kind of process takes a great mass of time and money. To overcome the disadvantage, tissue models were developed, firstly by traditional fabrication technologies without 3D printing. However, products by traditional methods revealed inaccurate models with unrealistic tissue status. With the application of 3D printing, biomimetic tissue models with high resolution are fabricated more efficiently at a lower cost than in the past. In this part, 3D printed tissue models of skin, liver, and tumor would be discussed.
Figure 7
Figure 8
The liver is a complex organ with multiple functions which have biotransformation effects on many non-nutritive substances (such as various drugs, poisons, and certain metabolites) in the body. They are completely decomposed by metabolism or excreted in the original form. With highly sensitive to drug toxicity, liver tissue engineering models were developed to take drug screening and testing. Reproducing the complex structures with 3D printing technology is the basic step for mimicking hepatic functions. To date, multiple fabrications of liver tissue models were accomplished with several 3D printing technologies. Ho-Joon Lee et al. developed multicellular 3D liver with multi-functions encapsulated in hybrid hydrogel (). HepaRG cells alone or with supporting cells were encapsulated in semi-IPNs (hydrogel) and printed with vat polymerization technology. Fabricated 3D liver model was verified to be functional maturation with a dynamic 3D microenvironment, which is important for disease modeling and drug testing. Huanhuan Joyce Chen et al. fabricated a 3D scaffold co-cultured with human intestinal cells (hIECs) and liver cells to mimic a two-organ body-on-chip situation (). The hIECs and liver cells in this scaffold were verified to maintain high viability and differentiable. While hIECs differentiated into human gastrointestinal cells, liver cells developed into lobule-like structures. Two organs on chip 3D model significantly improved the studies on human response and Inter-organ relationships. The two 3D liver models above were well fabricated and suitable for short-term studies. To realize long-term studies with functional liver tissue models, Hassan Rashidi et al. developed a stable 3D liver tissue model with certain function, which is testified for 1 year (). Mimicking realistic conditions, hexagonal scaffolds were fabricated with polycaprolactone embraced with self‐aggregated pluripotent stem cells (PSCs) spheroids. Embedding with PSCs-loaded implants, two mice models of tyrosinemia were claimed to heal without any infection. Emerging 3D liver tissue models are helping solving problems in an efficient and cost-effective way that we cannot imagine before.
As one of the largest organs in human body, skin covers the whole-body surface and plays an important role in protecting, excreting, regulating body temperature, and feeling external stimuli. For patients with extensive skin wounds, clinical therapies would be complicated and important. To test the efficacy and safety of treatment, skin tissue models reveal an irreplaceable role. Byoung Soo Kim et al. fabricated a 3D printing skin tissue model with skin-derived extracellular matrix (S-dECM) bioink (). Embraced in vivo with endothelial progenitor cells (EPCs) and adipose-derived stem cells (ASCs), 3D printing skin model accelerated wound healing especially in reepithelization and neovascularization. John W. Wills et al. adapted nanoparticles in 3D reconstructed skin micronucleus (RSMN) assay (). After normalizing the dose between the total nanoparticle mass and the cell number between 2D/3D assays, the 3D dose response was compared to the 2D micronucleus assay. Due to the protective properties of the 3D cell microstructure and the mixed barrier effect, tested silica particles revealed no (gene) toxicity for live cells in the 3D model comparing to the 2D assay. Plenty results suggested 3D skin model can more accurately reflect the toxicity of nanoparticle drugs on human skin function than traditional methods.
Tumor is a new pathological organism formed by the proliferation of local tissue cells under the action of various tumorigenic factors, and has an extremely complex microenvironment and microstructure. It is significant to mimic in vivo tumor environment with stroma and micro structures for the accuracy of testing new theories and therapies (). Jizhao Li et al. developed a 3D cell model with human lung cancer A549 cells applied in scaffolds fabricated with silk fibroin protein and chitosan (). By resembling pathological conditions, the 3D tumor model provide a valuable biomaterial platform for in-vitro test of antitumor drugs for non-small cell lung cancer. Yu Zhao et al. fabricated a 3D in vitro cervical tumor model with 3D printing of Hela cells in hydrogel grid structure by a layer-by-layer fashion (). With higher proliferation rate and matrix metalloproteinase protein expression, 3D cervical model fabricated with novel 3D printing technology is helping cervical tumor studies. Therefore, with the development of 3D printing tissue models, it is credible for the promising future that studies will be done more efficiently without sacrifices from experimental animals.
Medical Apparatus and Instruments
AM is a promising and novel technology for the production of medical apparatus and instruments comparing with traditional manufacturing techniques. Directed by patient's clinical images, custom-designed medical apparatus and surgical guides are fabricated efficiently and accurately. It brings anatomically fit to patients and surgical safety to surgeons. Besides, AM is capable of manufacturing complex microstructures which are not possible for conventional techniques (Figure 9). With these advantages, AM allows fast production with high resolution, few leftover material and low costs. In this section, discussion is focused on (i) prostheses and implants and () auxiliary medical equipment.
Figure 9
Medical implants and orthoses/prostheses (O&P) have been fabricated with traditional methods for decades. As with long term application, conservative implants revealed problems including anatomical mismatching, incompetent binding strength and initial stability, poor bone ingrowth and long-term stability, and low cost-efficiency (). All these problems have been solved with AM technology, which is capable to fabricate implants with proper surface and mechanical properties. Powder-based 3D printing techniques (SLM, SLS, and EBM) are widely applied in implants and O&P manufacturing as they are compatible with a wide range of printing materials, such as titanium alloy, zinc alloy, cobalt–chrome alloy, and polyetheretherketone (PEEK). With outstanding mechanical properties and biocompatibility, 3D printed implants have been applied in plenty of surgical majors, including tracheobronchial (; ), dentofacial, cardiovascular, orthopedic, and spine. For severe tracheobronchomalacia patients, a 3D printed self-expandable, metallic tracheobronchial stent fabricated with SLS technology was implanted into patient's collapse bronchus and rebuilt airway efficiently (). The printing technology offer a great opportunity of reconstruction and support for tracheobronchial diseases, which was difficult for conservative implants to be fabricated anatomically fitted. Besides self-expandable stent, a 3D printed bioresorbable stent was fabricated with SLS technique (). Printed bioresorbable stents were embedded into severe tracheobronchomalacia pig model, significant resolution of symptoms was observed. The stent was resorbed over time and was considered as a “4D” functional material. In maxillofacial and craniofacial surgeries, complex anatomy structures and irregular shapes of defects are the two most severe challenges. Conventionally, craniofacial prostheses are fabricated with hand-curved wax model for the anatomic defect with low precision. With 3D printing techniques, patient-customized prostheses are fabricated with guidance from CT or MRI images in which details for defects are well recorded. Kyle K et al. demonstrated the first application case of 3D printing in complex fetal craniofacial anomalies and perinatal management (). Researchers from Saint Louis University School of Medicine reviewed 315 patients who underwent 3D printing assisted maxillofacial and craniofacial surgeries (). Fabrications with 3D printing techniques were mainly focused on contour models, surgical guides, splints, and implants. These objects were mainly fabricated in factory and laboratory with an average time and cost of 18.9 h and $1,353.31 respectively. Without lab or proficiency with printing software, low-cost 3D maxillofacial models could be fabricated with a cost of only $90 (). While commercial models can be manufactured with serializable materials and advanced virtual planning, this low-cost method can generate models with high-fidelity as educational and surgical planning tools. Cardiac diseases have been widely studied with the assistance of 3D printing technology as it offers high-resolution reduction of pathological status (). Variety of printing techniques including material jetting (; ; ; ), FDM (; ), SLS, and SLA have been applied in the studies of structural heart disease, congenital heart disease, coronary arteries, and systemic vasculature. Benefiting from 3D printing techniques, advanced visualization (; ), diagnosis (), planning of surgeries, interventions (), education (; ), and researches (; ) in cardiovascular diseases are developing rapidly.
Conclusion
This paper reviews the advancements of 3D printing technologies applied in medical materials in recent years. With the superiority of patient-specific designs, high complexity, favorable productivity, and cost-effective manufacturing methods, 3D printing has been becoming widely accepted manufacturing technologies in the medical applications. The main applications of 3D printing in medicine include tissue engineering models, anatomical models, pharmacological designs and validation models, medical apparatus and instruments. Orthopedics is one of the most advanced fields that integrate 3D printing to produce end-use products such as restorations, spine models, and surgical navigation boards. Orthopedics is a pioneer in medical devices. Currently, there are many multiple 3D printed medical products on the market, including implantable craniofacial implants, acetabular cups, knee implants, spinal cages, and surgical instruments. In addition, about 99% of hearing aid housings are custom made through 3D printing. Pre-surgery printed anatomical models have revolutionized the way surgeons and medical students were trained for surgery. To date, researchers have printed about 16 different types of tissues, providing tissue models for high-throughput screening for new drugs. It is believed that 3D printing is affecting clinical and related basic research in an increasingly broader manner.
Funding
This research was funded by the Ministry of Science and Technology of China (2016YFB1101501 and 2018YFE0104200) and National Natural Science Foundation of China (NSFC, 51973226).
Statements
Author contributions
DF and YL contributed equally to this reviewed manuscript. XW, YT and ZL conceived and designed the content of the manuscript. DF, YL and XW collected the researched literatures, arranged the outline of collected documents and wrote the articles. TZ, QW, HC, and WL made important suggestions and helped revising the manuscript. All authors reviewed and commented on the entire manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The handling editor and reviewer JD declared their involvement as co-editors in the Research Topic, and confirm the absence of any other collaboration.
References
1
AhlfeldT.CidonioG.KilianD.DuinS.AkkineniA. R.DawsonJ. I.et al. (2017). Development of a clay based bioink for 3D cell printing for skeletal application. Biofabrication9 (3), 034103. doi: 10.1088/1758-5090/aa7e96
2
AhlfeldT.DoberenzF.KilianD.VaterC.KornP.LauerG.et al. (2018). Bioprinting of mineralized constructs utilizing multichannel plotting of a self-setting calcium phosphate cement and a cell-laden bioink. Biofabrication10 (4), 045002. doi: 10.1088/1758-5090/aad36d
3
AhnS. H.LeeJ.ParkS. A.KimW. D. (2016). Three-dimensional bio-printing equipment technologies for tissue engineering and regenerative medicine. Tissue Eng. Regener. Med.13 (6), 663–676. doi: 10.1007/s13770-016-0148-1
4
BartelT.RivardA.JimenezA.MestresC. A.MullerS. (2018). Medical three-dimensional printing opens up new opportunities in cardiology and cardiac surgery. Eur. Heart J.39 (15), 1246–1254. doi: 10.1093/eurheartj/ehx016
5
BrunelloG.SivolellaS.MeneghelloR.FerroniL.GardinC.PiattelliA.et al. (2016). Powder-based 3D printing for bone tissue engineering. Biotechnol. Adv.34 (5), 740–753. doi: 10.1016/j.biotechadv.2016.03.009
6
CarveM.WlodkowicD. (2018). 3D-Printed chips: compatibility of additive manufacturing photopolymeric substrata with biological applications. Micromachines (Basel)9 (2), E91. doi: 10.3390/mi9020091
7
ChenH. J.MillerP.ShulerM. L. (2018). A pumpless body-on-a-chip model using a primary culture of human intestinal cells and a 3D culture of liver cells. Lab. Chip18 (14), 2036–2046. doi: 10.1039/c8lc00111a
8
ChenY. R.ZhouZ. X.ZhangJ. Y.YuanF. Z.XuB. B.GuanJ.et al. (2019). Low-molecular-weight heparin-functionalized chitosan-chondroitin sulfate hydrogels for controlled release of TGF-beta3 and in vitro neocartilage formation. Front. Chem.7, 745. doi: 10.3389/fchem.2019.00745
9
CostaE. C.MoreiraA. F.de Melo-DiogoD.GasparV. M.CarvalhoM. P.CorreiaI. J. (2016). 3D tumor spheroids: an overview on the tools and techniques used for their analysis. Biotechnol. Adv.34 (8), 1427–1441. doi: 10.1016/j.biotechadv.2016.11.002
10
CrediC.FioreseA.TironiM.BernasconiR.MagagninL.LeviM.et al. (2016). 3D Printing of cantilever-type microstructures by stereolithography of ferromagnetic photopolymers. ACS Appl. Mater Interfaces8 (39), 26332–26342. doi: 10.1021/acsami.6b08880
11
CrediC.GriffiniG.LeviM.TurriS. (2018). Biotinylated photopolymers for 3d-printed unibody lab-on-a-chip optical platforms. Small14 (1), 1702831. doi: 10.1002/smll.201702831
12
DittmannW.BillJ.WittenbergG.ReutherJ.RoosenK. (1994). [Stereolithography as a new method of reconstructive surgical planning in complex osseous defects of the cranial base. Tech. note]. Zentralbl Neurochir55 (4), 209–211.
13
EltoraiA. E.NguyenE.DanielsA. H. (2015). Three-dimensional printing in orthopedic surgery. Orthopedics38 (11), 684–687. doi: 10.3928/01477447-20151016-05
14
FedoreC. W.TseL. Y. L.NamH. K.BartonK. L.HatchN. E. (2017). Analysis of polycaprolactone scaffolds fabricated via precision extrusion deposition for control of craniofacial tissue mineralization. Orthod. Craniofac. Res.20 Suppl 1, 12–17. doi: 10.1111/ocr.12159
15
FinaF.GoyanesA.GaisfordS.BasitA. W. (2017). Selective laser sintering (SLS) 3D printing of medicines. Int. J. Pharm.529 (1-2), 285–293. doi: 10.1016/j.ijpharm.2017.06.082
16
GanguliA.Pagan-DiazG. J.GrantL.CvetkovicC.BramletM.VozenilekJ.et al. (2018). 3D printing for preoperative planning and surgical training: a review. BioMed. Microdevices20 (3), 65. doi: 10.1007/s10544-018-0301-9
17
GiannopoulosA. A.MitsourasD.YooS. J.LiuP. P.ChatzizisisY. S.RybickiF. J. (2016). Applications of 3D printing in cardiovascular diseases. Nat. Rev. Cardiol.13 (12), 701–718. doi: 10.1038/nrcardio.2016.170
18
GrahamA. D.OlofS. N.BurkeM. J.ArmstrongJ. P. K.MikhailovaE. A.NicholsonJ. G.et al. (2017). High-resolution patterned cellular constructs by droplet-based 3D printing. Sci. Rep.7 (1), 7004. doi: 10.1038/s41598-017-06358-x
19
HanY.YangS.HuangW.WangZ.LiH. (2018). A hem-o-lok-induced tracheoesophageal fistula cured by temporary airway stenting modified with three-dimensional printing. Ann. Thorac. Surg.106 (4), e219–e221. doi: 10.1016/j.athoracsur.2018.04.037
20
Heidari KeshelS.RostampourM.KhosropourG.BandbonB. A.Baradaran-RafiiA.BiazarE. (2016). Derivation of epithelial-like cells from eyelid fat-derived stem cells in thermosensitive hydrogel. J. Biomater. Sci. Polym. Ed. 27 (4), 339–350. doi: 10.1080/09205063.2015.1130406
21
HongD.ChouD. T.VelikokhatnyiO. I.RoyA.LeeB.SwinkI.et al. (2016). Binder-jetting 3D printing and alloy development of new biodegradable Fe-Mn-Ca/Mg alloys. Acta Biomater. 45, 375–386. doi: 10.1016/j.actbio.2016.08.032
22
HungK. C.TsengC. S.DaiL. G.HsuS. H. (2016). Water-based polyurethane 3D printed scaffolds with controlled release function for customized cartilage tissue engineering. Biomaterials83, 156–168. doi: 10.1016/j.biomaterials.2016.01.019
23
IshutovS.HasiukF. J.JobeD.AgarS. (2018). Using resin-based 3D printing to build geometrically accurate proxies of porous sedimentary rocks. Ground Water56 (3), 482–490. doi: 10.1111/gwat.12601
24
JacobsC. A.LinA. Y. (2017). A new classification of three-dimensional printing technologies: systematic review of three-dimensional printing for patient-specific craniomaxillofacial surgery. Plast. Reconstr. Surg.139 (5), 1211–1220. doi: 10.1097/PRS.0000000000003232
25
JamrozW.SzafraniecJ.KurekM.JachowiczR. (2018). 3D Printing in pharmaceutical and medical applications - recent achievements and challenges. Pharm. Res.35 (9), 176. doi: 10.1007/s11095-018-2454-x
26
KimB. S.KwonY. W.KongJ. S.ParkG. T.GaoG.HanW.et al. (2018). 3D cell printing of in vitro stabilized skin model and in vivo pre-vascularized skin patch using tissue-specific extracellular matrix bioink: a step towards advanced skin tissue engineering. Biomaterials168, 38–53. doi: 10.1016/j.biomaterials.2018.03.040
27
KimD. H.LeeJ.BaeJ.ParkS.ChoiJ.LeeJ. H.et al. (2018). Mechanical analysis of ceramic/polymer composite with mesh-type lightweight design using binder-Jet 3D printing. Materials (Basel)11 (10), E1941. doi: 10.3390/ma11101941
28
KontaA. A.Garcia-PinaM.SerranoD. R. (2017). Personalised 3D printed medicines: which techniques and polymers are more successful?Bioengineering. (Basel)4 (4), E79. doi: 10.3390/bioengineering4040079
29
LarondaM. M.RutzA. L.XiaoS.WhelanK. A.DuncanF. E.RothE. W.et al. (2017). A bioprosthetic ovary created using 3D printed microporous scaffolds restores ovarian function in sterilized mice. Nat. Commun.8, 15261. doi: 10.1038/ncomms15261
30
LauI. W. W.LiuD.XuL.FanZ.SunZ. (2018). Clinical value of patient-specific three-dimensional printing of congenital heart disease: quantitative and qualitative assessments. PLoS One13 (3), e0194333. doi: 10.1371/journal.pone.0194333
31
LeeH. J.SonM. J.AhnJ.OhS. J.LeeM.KimA.et al. (2017). Elasticity-based development of functionally enhanced multicellular 3D liver encapsulated in hybrid hydrogel. Acta Biomater. 64, 67–79. doi: 10.1016/j.actbio.2017.09.041
32
LegockiA. T.Duffy-PeterA.ScottA. R. (2017). Benefits and limitations of entry-level 3-dimensional printing of maxillofacial skeletal models. JAMA Otolaryngol Head Neck Surg.143 (4), 389–394. doi: 10.1001/jamaoto.2016.3673
33
LiJ.ZhouY.ChenW.YuanZ.YouB.LiuY.et al. (2018). A novel 3D in vitro tumor model based on silk fibroin/chitosan scaffolds to mimic the tumor microenvironment. ACS Appl. Mater. Interfaces10 (43), 36641–36651. doi: 10.1021/acsami.8b10679
34
LiawC. Y.GuvendirenM. (2017). Current and emerging applications of 3D printing in medicine. Biofabrication9 (2), 024102. doi: 10.1088/1758-5090/aa7279
35
LindJ. U.BusbeeT. A.ValentineA. D.PasqualiniF. S.YuanH.YadidM.et al. (2017). Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing. Nat. Mater16 (3), 303–308. doi: 10.1038/nmat4782
36
MahajanA.FrisbieC. D.FrancisL. F. (2013). Optimization of aerosol jet printing for high-resolution, high-aspect ratio silver lines. ACS Appl. Mater. Interfaces5 (11), 4856–4864. doi: 10.1021/am400606y
37
MahmoodF.OwaisK.TaylorC.Montealegre-GallegosM.ManningW.MatyalR.et al. (2015). Three-dimensional printing of mitral valve using echocardiographic data. JACC Cardiovasc. Imaging8 (2), 227–229. doi: 10.1016/j.jcmg.2014.06.020
38
MarketsandMarkets (2019). 3D printing market by offering, process, application, vertical, technology, and geography - global forecast to 2024. Retrieved from https://www.marketsandmarkets.com/Market-Reports/3d-printing-market-1276.html.
39
MarkstedtK.EscalanteA.TorizG.GatenholmP. (2017). Biomimetic inks based on cellulose nanofibrils and cross-linkable xylans for 3d printing. ACS Appl. Mater. Interfaces9 (46), 40878–40886. doi: 10.1021/acsami.7b13400
40
MitsourasD.LiacourasP.ImanzadehA.GiannopoulosA. A.CaiT.KumamaruK. K.et al. (2015). Medical 3D printing for the radiologist. Radiographics35 (7), 1965–1988. doi: 10.1148/rg.2015140320
41
MondscheinR. J.KanitkarA.WilliamsC. B.VerbridgeS. S.LongT. E. (2017). Polymer structure-property requirements for stereolithographic 3D printing of soft tissue engineering scaffolds. Biomaterials140, 170–188. doi: 10.1016/j.biomaterials.2017.06.005
42
MukherjeeP.ChengK.FlanaganS.GreenbergS. (2017). Utility of 3D printed temporal bones in pre-surgical planning for complex BoneBridge cases. Eur. Arch. Otorhinolaryngol.274 (8), 3021–3028. doi: 10.1007/s00405-017-4618-4
43
MurphyS. V.AtalaA. (2014). 3D bioprinting of tissues and organs. Nat. Biotechnol.32 (8), 773–785. doi: 10.1038/nbt.2958
44
NieW.GuF.WangZ.WuR.YueY.ShaoA. (2019). Preliminary application of three-dimension printing technology in surgical management of bicondylar tibial plateau fractures. Injury50 (2), 476–483. doi: 10.1016/j.injury.2018.12.019
45
NingL.ChenX. (2017). A brief review of extrusion-based tissue scaffold bio-printing. Biotechnol. J.12 (8), 1600671. doi: 10.1002/biot.201600671
46
NormanJ.MaduraweR. D.MooreC. M.KhanM. A.KhairuzzamanA. (2017). A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv. Drug Delivery Rev.108, 39–50. doi: 10.1016/j.addr.2016.03.001
47
OlivieriL. J.KriegerA.LokeY. H.NathD. S.KimP. C.SableC. A. (2015). Three-dimensional printing of intracardiac defects from three-dimensional echocardiographic images: feasibility and relative accuracy. J. Am. Soc. Echocardiogr.28 (4), 392–397. doi: 10.1016/j.echo.2014.12.016
48
OrsiG.De MariaC.MontemurroF.ChauhanV. M.AylottJ. W.VozziG. (2015). Combining inkjet printing and sol-gel chemistry for making pH-sensitive surfaces. Curr. Top. Med. Chem.15 (3), 271–278. doi: 10.2174/1568026614666141229114738
49
OsmanR. B.AlharbiN.WismeijerD. (2017). Build angle: does it influence the accuracy of 3d-printed dental restorations using digital light-processing technology?Int. J. Prosthodont.30 (2), 182–188. doi: 10.11607/ijp.5117
50
OzbolatI. T.HospodiukM. (2016). Current advances and future perspectives in extrusion-based bioprinting. Biomaterials76, 321–343. doi: 10.1016/j.biomaterials.2015.10.076
51
PaxtonN.SmolanW.BockT.MelchelsF.GrollJ.JungstT. (2017). Proposal to assess printability of bioinks for extrusion-based bioprinting and evaluation of rheological properties governing bioprintability. Biofabrication9 (4), 044107. doi: 10.1088/1758-5090/aa8dd8
52
PettaD.ArmientoA. R.GrijpmaD.AliniM.EglinD.D'EsteM. (2018). 3D bioprinting of a hyaluronan bioink through enzymatic-and visible light-crosslinking. Biofabrication10 (4), 044104. doi: 10.1088/1758-5090/aadf58
53
PlaconeJ. K.EnglerA. J. (2018). Recent advances in extrusion-based 3D printing for biomedical applications. Adv. Healthc Mater7 (8), e1701161. doi: 10.1002/adhm.201701161
54
RahmanZ.Barakh AliS. F.OzkanT.CharooN. A.ReddyI. K.KhanM. A. (2018). Additive manufacturing with 3D printing: progress from bench to bedside. AAPS J.20 (6), 101. doi: 10.1208/s12248-018-0225-6
55
RashidiH.LuuN. T.AlwahshS. M.GinaiM.AlhaqueS.DongH.et al. (2018). 3D human liver tissue from pluripotent stem cells displays stable phenotype in vitro and supports compromised liver function in vivo. Arch. Toxicol.92 (10), 3117–3129. doi: 10.1007/s00204-018-2280-2
56
Revilla-LeonM.OzcanM. (2019). Additive manufacturing technologies used for processing polymers: current status and potential application in prosthetic dentistry. J. Prosthodont.28 (2), 146–158. doi: 10.1111/jopr.12801
57
SerexL.BertschA.RenaudP. (2018). Microfluidics: a new layer of control for extrusion-based 3d printing. Micromachines (Basel)9 (2), E86. doi: 10.3390/mi9020086
58
SmithM. L.JonesJ. F. X. (2018). Dual-extrusion 3D printing of anatomical models for education. Anat. Sci. Educ.11 (1), 65–72. doi: 10.1002/ase.1730
59
SonK. H.KimK. W.AhnC. B.ChoiC. H.ParkK. Y.ParkC. H.et al. (2015). Surgical Planning by 3D Printing for Primary Cardiac Schwannoma Resection. Yonsei Med. J.56 (6), 1735–1737. doi: 10.3349/ymj.2015.56.6.1735
60
StefaniakA. B.BowersL. N.KneppA. K.LuxtonT. P.PeloquinD. M.BaumannE. J.et al. (2019). Particle and vapor emissions from vat polymerization desktop-scale 3-dimensional printers. J. Occup. Environ. Hyg.16 (8), 519–531. doi: 10.1080/15459624.2019.1612068
61
SuW.XiaoY.HeS.HuangP.DengX. (2018). Three-dimensional printing models in congenital heart disease education for medical students: a controlled comparative study. BMC Med. Educ.18 (1), 178. doi: 10.1186/s12909-018-1293-0
62
TahayeriA.MorganM.FugolinA. P.BompolakiD.AthirasalaA.PfeiferC. S.et al. (2018). 3D printed versus conventionally cured provisional crown and bridge dental materials. Dent. Mater.34 (2), 192–200. doi: 10.1016/j.dental.2017.10.003
63
TaylorS. L.IbehA. J.JakusA. E.ShahR. N.DunandD. C. (2018). NiTi-Nb micro-trusses fabricated via extrusion-based 3D-printing of powders and transient-liquid-phase sintering. Acta Biomater.76, 359–370. doi: 10.1016/j.actbio.2018.06.015
64
TrenfieldS. J.AwadA.GoyanesA.GaisfordS.BasitA. W. (2018). 3D Printing pharmaceuticals: drug development to frontline care. Trends Pharmacol. Sci.39 (5), 440–451. doi: 10.1016/j.tips.2018.02.006
65
VanKoeveringK. K.MorrisonR. J.PrabhuS. P.TorresM. F.MychaliskaG. B.TreadwellM. C.et al. (2015). Antenatal three-dimensional printing of aberrant facial anatomy. Pediatrics136 (5), e1382–e1385. doi: 10.1542/peds.2015-1062
66
VukicevicM.MosadeghB.MinJ. K.LittleS. H. (2017). Cardiac 3D Printing and its Future Directions. JACC Cardiovasc. Imaging10 (2), 171–184. doi: 10.1016/j.jcmg.2016.12.001
67
WangX.GaoP.YangY.GuoH.WuD. (2018a). Dynamic and programmable morphology and size evolution via a living hierarchical self-assembly strategy. Nat. Commun.9 (1), 2772. doi: 10.1038/s41467-018-05142-3
68
WangX.YangY.FanL.YangF.WuD. (2018b). POSS-embedded supramolecular hyperbranched polymers constructed from a 1→7 branching monomer with controllable morphology transitions. China Chem.61, 3, 311–318. doi: 10.1007/s11426-017-9168-3
69
WangS. J.JiangD.ZhangZ. Z.ChenY. R.YangZ. D.ZhangJ. Y.et al. (2019). Biomimetic nanosilica-collagen scaffolds for in situ bone regeneration: toward a cell-free, one-step surgery. Adv. Mater.31 (49), e1904341. doi: 10.1002/adma.201904341
70
WeiR.GuoW.JiT.ZhangY.LiangH. (2017). One-step reconstruction with a 3D-printed, custom-made prosthesis after total en bloc sacrectomy: a technical note. Eur. Spine J.26 (7), 1902–1909. doi: 10.1007/s00586-016-4871-z
71
WeinhartM.HockeA.HippenstielS.KurreckJ.HedtrichS. (2019). 3D organ models-Revolution in pharmacological research?Pharmacol. Res.139, 446–451. doi: 10.1016/j.phrs.2018.11.002
72
WillsJ. W.HondowN.ThomasA. D.ChapmanK. E.FishD.MaffeisT. G.et al. (2016). Genetic toxicity assessment of engineered nanoparticles using a 3D in vitro skin model (EpiDerm). Part Fibre Toxicol.13 (1), 50. doi: 10.1186/s12989-016-0161-5
73
WollhofenR.AxmannM.FreudenthalerP.GabrielC.RohrlC.StanglH.et al. (2018). Multiphoton-Polymerized 3D Protein Assay. ACS Appl. Mater. Interfaces10 (2), 1474–1479. doi: 10.1021/acsami.7b13183
74
WongJ. Y. (2016). 3D printing applications for space missions. Aerosp Med. Hum. Perform.87 (6), 580–582. doi: 10.3357/AMHP.4633.2016
75
WysockiB.IdaszekJ.ZdunekJ.RozniatowskiK.PisarekM.YamamotoA.et al. (2018). The influence of selective laser melting (SLM) process parameters on in-vitro cell response. Int. J. Mol. Sci., 19(6), E1619. doi: 10.3390/ijms19061619
76
XuN.WeiF.LiuX.JiangL.CaiH.LiZ.et al. (2016). Reconstruction of the upper cervical spine using a personalized 3d-printed vertebral body in an adolescent with ewing sarcoma. Spine (Phila Pa 1976)41 (1), E50–E54. doi: 10.1097/BRS.0000000000001179
77
YangY.WangX.YangF.WangL.WuD. (2018). Highly elastic and ultratough hybrid ionic-covalent hydrogels with tunable structures and mechanics. Adv. Mater.30 (18), e1707071. doi: 10.1002/adma.201707071
78
YuanB.ZhouS. Y.ChenX. S. (2017). Rapid prototyping technology and its application in bone tissue engineering. J. Zhejiang Univ. Sci. B18 (4), 303–315. doi: 10.1631/jzus.B1600118
79
ZanchettaE.CattaldoM.FranchinG.SchwentenweinM.HomaJ.BrusatinG.et al. (2016). Stereolithography of SiOC ceramic microcomponents. Adv. Mater. 28 (2), 370–376. doi: 10.1002/adma.201503470
80
ZhaoY.YaoR.OuyangL.DingH.ZhangT.ZhangK.et al. (2014). Three-dimensional printing of Hela cells for cervical tumor model in vitro. Biofabrication6 (3), 035001. doi: 10.1088/1758-5082/6/3/035001
81
ZhuC.XiaY.ZaiY.DaiY.LiuX.BianJ.et al. (2019). Adsorption and desorption behaviors of HPEI and thermoresponsive HPEI based gels on anionic and cationic dyes. Chem. Eng. J.369, 863–873. doi: 10.1016/j.cej.2019.03.169
82
ZopfD. A.FlanaganC. L.WheelerM.HollisterS. J.GreenG. E. (2014). Treatment of severe porcine tracheomalacia with a 3-dimensionally printed, bioresorbable, external airway splint. JAMA Otolaryngol. Head Neck Surg.140 (1), 66–71. doi: 10.1001/jamaoto.2013.5644
Summary
Keywords
additive manufacturing, 3D printing, functional biomaterials, tissue engineering, 3D pharmacological models, medical apparatus
Citation
Fan D, Li Y, Wang X, Zhu T, Wang Q, Cai H, Li W, Tian Y and Liu Z (2020) Progressive 3D Printing Technology and Its Application in Medical Materials. Front. Pharmacol. 11:122. doi: 10.3389/fphar.2020.00122
Received
01 December 2019
Accepted
28 January 2020
Published
20 March 2020
Volume
11 - 2020
Edited by
Wei Tao, Changchun Institute of Applied Chemistry (CAS), China
Reviewed by
Yang Han, Ludwig Maximilian University of Munich, Germany; Jianxun Ding, Changchun Institute of Applied Chemistry (CAS), China
Updates
Copyright
© 2020 Fan, Li, Wang, Zhu, Wang, Cai, Li, Tian and Liu.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Xing Wang, wangxing@iccas.ac.cn; Yun Tian, tiany@bjmu.edu.cn; Zhongjun Liu, zjliu@bjmu.edu.cn
†These authors have contributed equally to this work
This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.